Get the Stockscreener App
21.95
0.14%
0.03
After Hours:
21.95
Progyny Inc stock is traded at $21.95, with a volume of 1.01M.
It is up +0.14% in the last 24 hours and down -17.70% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$21.92
Open:
$21.93
24h Volume:
1.01M
Relative Volume:
0.65
Market Cap:
$1.89B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
34.84
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
-8.04%
1M Performance:
-17.70%
6M Performance:
-6.56%
1Y Performance:
+0.55%
1-Day Range:
$21.49
$22.45
1-Week Range:
$21.49
$24.32
52-Week Range:
$17.98
$28.75
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, CI, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
21.95 | 1.89B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
276.65 | 243.26B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
78.35 | 96.90B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
CI
Cigna Group
|
292.05 | 74.96B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
338.98 | 73.84B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
193.94 | 23.28B | 126.36B | 1.30B | 1.55B | 10.67 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-12-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Progyny’s Financial Milestone: Upcoming Report to Set Direction - AD HOC NEWS
Progyny, Inc. $PGNY Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Sees Significant Decline in Short Interest - MarketBeat
Progyny (NASDAQ:PGNY) Aligns With Nasdaq 100 Composition Healthcare Themes - Kalkine Media
Assessing Progyny (PGNY) Valuation After Recent Share Pullback And 3‑Month Rebound - Yahoo Finance
(PGNY) Risk Channels and Responsive Allocation - Stock Traders Daily
105,000 Shares in Progyny, Inc. $PGNY Acquired by Hussman Strategic Advisors Inc. - MarketBeat
Progyny, Inc. (PGNY) Investor Outlook: Analyzing a Promising 24.43% Potential Upside in Healthcare Plans - DirectorsTalk Interviews
Kornitzer Capital Management Inc. KS Sells 85,000 Shares of Progyny, Inc. $PGNY - MarketBeat
Progyny Inc (NASDAQ:PGNY) Combines Strong Fundamentals with Bullish Technical Setup - Chartmill
Published on: 2026-01-27 11:06:26 - baoquankhu1.vn
US Market Recap: Why is Progyny Inc stock going downMarket Movers & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Bull Run: Is Progyny Inc forming a bullish divergenceMarket Activity Report & Precise Swing Trade Alerts - baoquankhu1.vn
Progyny, Inc. (PGNY) supported by analysts as earnings visibility improves - MSN
Hedge Fund Bets: How do insiders feel about ProShares Trust ProShares Ultra SemiconductorsJuly 2025 Price Swings & Expert Approved Trade Ideas - baoquankhu1.vn
Wall Street Recap: What analysts say about Progyny Inc stockTrade Risk Assessment & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Progyny price target raised to $35 from $30 at BTIG - Yahoo Finance
SG Americas Securities LLC Cuts Stock Position in Progyny, Inc. $PGNY - MarketBeat
Progyny, Inc. (PGNY) Supported by Analysts as Earnings Visibility Improves - Insider Monkey
Progyny Shows Rising Price Performance With Jump To 82 RS Rating - Investor's Business Daily
ETF Watch: Is Progyny Inc stock technically oversold2025 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn
Progyny (PGNY) Stock Rises on Analyst Upgrade to Market Outperform | 2026 OutlookNews and Statistics - IndexBox
Progyny (PGNY) Stock Is Up, What You Need To Know - Finviz
Progyny sees IBD RS rating climb to 77 - MSN
Forecasting The Future: 6 Analyst Projections For Progyny - Benzinga
Progyny (NASDAQ:PGNY) Upgraded by Citizens Jmp to "Market Outperform" Rating - MarketBeat
Citizens Upgrades Progyny (PGNY) - Nasdaq
PGNY Stock Rating Upgraded by Citizens to Market Outperform | PG - GuruFocus
Progyny stock rating upgraded by Citizens on strong retention rates - Investing.com Canada
This Intel Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Progyny president’s employment to end December 2025 - MSN
Short Interest in Progyny, Inc. (NASDAQ:PGNY) Declines By 23.3% - MarketBeat
(PGNY) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Can Progyny’s (PGNY) Modest Guidance Raise Redefine Its Demand Resilience Narrative? - Yahoo Finance
Stock Picks for 2026: e.l.f. Beauty to Buy, American Woodmark & Progyny to SellNews and Statistics - IndexBox
Pullback Watch: Why is Progyny Inc stock going downJuly 2025 Levels & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Progyny Inc (PGNY) Shares Gap Down to $24.7608 on Jan 15 - GuruFocus
Stocks Flashing Renewed Technical Strength: Progyny - Investor's Business Daily
Aug Setups: Is Progyny Inc impacted by rising rates2025 Bull vs Bear & Expert Curated Trade Setups - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Regeneron (REGN) and Progyny (PGNY) - The Globe and Mail
Progyny (NASDAQ:PGNY) Reaches New 1-Year HighTime to Buy? - MarketBeat
Progyny Stock (-11%) : JPM Conference Growth Narrative Fails to Impress - Trefis
Progyny, Inc. (NASDAQ:PGNY) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Progyny (NASDAQ:PGNY) Shares Down 5.9%Time to Sell? - MarketBeat
Progyny, Inc.'s (NASDAQ:PGNY) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? - 富途牛牛
Progyny stock to exceed guidance as BofA reiterates Buy rating By Investing.com - Investing.com Canada
Progyny stock to exceed guidance as BofA reiterates Buy rating - Investing.com
Zacks Industry Outlook Highlights Medpace, Enhabit and Progyny - Yahoo Finance
Progyny to discuss updated financial expectations at upcoming JP Morgan healthcare conference - marketscreener.com
Progyny To Discuss Updated Financial Expectations At Upcoming JP Morgan Healthcare Conference - TradingView
Progyny Inc anticipates Q4 and full year results to be slightly above previously provided financial guidance - marketscreener.com
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.16%
2.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):